An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies

The 5th edition of the World Health Organisation (WHO) “Classification of Thoracic Tumours” replaces the previous edition from 2015, which was released in 2021. The new edition includes specific diagnostic criteria for each entity and lays a stronger emphasis on diagnostic molecular pathology. Immun...

Full description

Bibliographic Details
Main Authors: Gyanendra Singh, Anurag Singh, Rushang Dave
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2023-06-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/18076/62583_CE[Ra1]_F(IS)_PF1(HB_SHU_KM)_PFA(HB_KM)_PN(KM).pdf
_version_ 1797797234321915904
author Gyanendra Singh
Anurag Singh
Rushang Dave
author_facet Gyanendra Singh
Anurag Singh
Rushang Dave
author_sort Gyanendra Singh
collection DOAJ
description The 5th edition of the World Health Organisation (WHO) “Classification of Thoracic Tumours” replaces the previous edition from 2015, which was released in 2021. The new edition includes specific diagnostic criteria for each entity and lays a stronger emphasis on diagnostic molecular pathology. Immunohistochemistry (IHC) was heavily promoted in 2015, as a way to improve classification precision. The book places more attention on molecular pathology developments for all tumour types in 2021. Classification based on microscopic biopsy samples of the characteristics of lung cancer is an alternative to resection-based categorisation. A grading system for invasive non mucinous adenocarcinomas has been developed, using the percentage of distinctive histological patterns found inside each tumour. Lung adenocarcinoma is also predisposed by Tumour Spread Through Air Spaces (STAS). A basaloid variety of Squamous Cell Carcinoma (SCC) and lymphoepithelial carcinoma was added to the SCC group. The ciliated muconodular papillary tumour and thoracic SMARCA4-deficient undifferentiated carcinoma are recent inclusions. Therefore, the following new terms and entities have been added to the WHO classification of 2021: (1) Thoracic SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 (SMARCA4)-deficient undifferentiated tumour; (2) Bronchiolar adenoma/ciliated muconodular papillary tumour; (3) Primary pulmonary hyalinising clear cell carcinoma of lung; (4) Lypmphoepithelial carcinoma; (5) STAS.
first_indexed 2024-03-13T03:45:07Z
format Article
id doaj.art-eeb3381f5b2942fcbc0c2ab6f3fa6e3a
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-03-13T03:45:07Z
publishDate 2023-06-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-eeb3381f5b2942fcbc0c2ab6f3fa6e3a2023-06-23T04:18:56ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2023-06-01176EE01EE0510.7860/JCDR/2023/62583.18076An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and TerminologiesGyanendra Singh0Anurag Singh1Rushang Dave2Assistant Professor, Department of Pathology, All India Institute of Medical Sciences, Rajkot, Gujarat, India.Senior Resident, Department of Pathology, KGMU, Lucknow, Uttar Pradesh, India.Senior Resident, Department of Pathology, All India Institute of Medical Sciences, Rajkot, Gujarat, India.The 5th edition of the World Health Organisation (WHO) “Classification of Thoracic Tumours” replaces the previous edition from 2015, which was released in 2021. The new edition includes specific diagnostic criteria for each entity and lays a stronger emphasis on diagnostic molecular pathology. Immunohistochemistry (IHC) was heavily promoted in 2015, as a way to improve classification precision. The book places more attention on molecular pathology developments for all tumour types in 2021. Classification based on microscopic biopsy samples of the characteristics of lung cancer is an alternative to resection-based categorisation. A grading system for invasive non mucinous adenocarcinomas has been developed, using the percentage of distinctive histological patterns found inside each tumour. Lung adenocarcinoma is also predisposed by Tumour Spread Through Air Spaces (STAS). A basaloid variety of Squamous Cell Carcinoma (SCC) and lymphoepithelial carcinoma was added to the SCC group. The ciliated muconodular papillary tumour and thoracic SMARCA4-deficient undifferentiated carcinoma are recent inclusions. Therefore, the following new terms and entities have been added to the WHO classification of 2021: (1) Thoracic SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 (SMARCA4)-deficient undifferentiated tumour; (2) Bronchiolar adenoma/ciliated muconodular papillary tumour; (3) Primary pulmonary hyalinising clear cell carcinoma of lung; (4) Lypmphoepithelial carcinoma; (5) STAS.https://jcdr.net/articles/PDF/18076/62583_CE[Ra1]_F(IS)_PF1(HB_SHU_KM)_PFA(HB_KM)_PN(KM).pdfbronchiolar adenomaciliated muconodular papillary tumoursquamous cell carcinomaworld health organisation
spellingShingle Gyanendra Singh
Anurag Singh
Rushang Dave
An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies
Journal of Clinical and Diagnostic Research
bronchiolar adenoma
ciliated muconodular papillary tumour
squamous cell carcinoma
world health organisation
title An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies
title_full An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies
title_fullStr An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies
title_full_unstemmed An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies
title_short An Update on WHO Classification of Thoracic Tumours 2021- Newly Described Entities and Terminologies
title_sort update on who classification of thoracic tumours 2021 newly described entities and terminologies
topic bronchiolar adenoma
ciliated muconodular papillary tumour
squamous cell carcinoma
world health organisation
url https://jcdr.net/articles/PDF/18076/62583_CE[Ra1]_F(IS)_PF1(HB_SHU_KM)_PFA(HB_KM)_PN(KM).pdf
work_keys_str_mv AT gyanendrasingh anupdateonwhoclassificationofthoracictumours2021newlydescribedentitiesandterminologies
AT anuragsingh anupdateonwhoclassificationofthoracictumours2021newlydescribedentitiesandterminologies
AT rushangdave anupdateonwhoclassificationofthoracictumours2021newlydescribedentitiesandterminologies
AT gyanendrasingh updateonwhoclassificationofthoracictumours2021newlydescribedentitiesandterminologies
AT anuragsingh updateonwhoclassificationofthoracictumours2021newlydescribedentitiesandterminologies
AT rushangdave updateonwhoclassificationofthoracictumours2021newlydescribedentitiesandterminologies